Christopher Gasparis: Anticoagulation After Atrial Fibrillation Ablation – Long-Term Impact on Stroke
Christopher Gasparis, Surgery Resident at Northwell Health, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Heart Rhythm O2, adding:
“Excited to share our new ITHACA database publication in Heart Rhythm O2!
We investigated the long-term risk of stroke in select patients with elevated CHA2DS2-VASc score who discontinued anticoagulation following atrial fibrillation ablation.
A big thank you to my mentors Stavros Mountantonakis and Kristie Coleman and my coauthors Stefanos Zafeiropoulos, Jonas Leavitt, Elliot Wolf, Ari Zimmer, Rajat Goyal and Dr. Laurence Epstein for their guidance and contributions.”
Title: Anticoagulation Decision Based on Atrial Fibrillation Ablation Outcomes and Long-Term Impact on Stroke. An ITHACA Database Study
Authors: Christopher Gasparis, Stefanos Zafeiropoulos, Jonas Leavitt, Elliot Wolf, Ari Zimmer, Rajat Goyal, Laurence M. Epstein, Kristie M. Coleman, Stavros E. Mountantonakis.

Stay updated with Hemostasis Today.
-
Nov 14, 2026, 00:23Saji Kumar: The Role of Agentic AI in Blood Bank Inventory Coordination
-
Nov 14, 2026, 00:04Carlos A. Metidieri Menegozzo: The First Priority in Trauma Transfusion May Be Time to First Blood Product
-
Nov 13, 2026, 23:43Alamgir Hosen Ronit: Corrected Platelet Count in EDTA Induced Platelet Aggregation
-
Nov 13, 2026, 23:32Evi Loos: Can PRP Improve Pain in Thumb Base Osteoarthritis?
-
Nov 13, 2026, 23:10Cesar de Almeida Neto: Digital Connectivity Can Transform Plateletpheresis Practice
-
Nov 13, 2026, 23:10Chien-Wen Liew: Where PRP Actually Sits in the Evidence
-
Nov 13, 2026, 23:08Erika Koppers: Continuing the Collaborative Journey Towards Equitable Haemophilia Care in South Africa
-
Nov 13, 2026, 23:06Büşra Ece Günaydın: A New Approach to Factor VIII Gene Insertion for Hemophilia A
-
Nov 13, 2026, 22:57Rolf Bekendam: Moderating a Conversation With Experts on Rare Bleeding Disorders